Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
23-1
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #30315
advertisement
Yang X
19
Showing records 1 to 19 |
Display all abstracts from
Yang X
100337
Clinical Analysis of Pediatric Glaucoma in Central China
Liu Q
Frontiers in medicine
2022; 9: 874369
100683
Gastrodin protects retinal ganglion cells from ischemic injury by activating phosphatidylinositol 3-kinase/protein kinase B/nuclear factor erythroid 2-related factor 2 (PI3K/AKT/Nrf2) signaling pathway
Li S
Bioengineered
2022; 13: 12625-12636
100469
Genome-wide association and Mendelian randomization study of blood copper levels and 213 deep phenotypes in humans
Yang W; Li L
Communications biology
2022; 5: 405
100337
Clinical Analysis of Pediatric Glaucoma in Central China
Liu C
Frontiers in medicine
2022; 9: 874369
100683
Gastrodin protects retinal ganglion cells from ischemic injury by activating phosphatidylinositol 3-kinase/protein kinase B/nuclear factor erythroid 2-related factor 2 (PI3K/AKT/Nrf2) signaling pathway
Yang Q; Zhou Z
Bioengineered
2022; 13: 12625-12636
100469
Genome-wide association and Mendelian randomization study of blood copper levels and 213 deep phenotypes in humans
Feng X
Communications biology
2022; 5: 405
100337
Clinical Analysis of Pediatric Glaucoma in Central China
Li H
Frontiers in medicine
2022; 9: 874369
100683
Gastrodin protects retinal ganglion cells from ischemic injury by activating phosphatidylinositol 3-kinase/protein kinase B/nuclear factor erythroid 2-related factor 2 (PI3K/AKT/Nrf2) signaling pathway
Yang X
Bioengineered
2022; 13: 12625-12636
100469
Genome-wide association and Mendelian randomization study of blood copper levels and 213 deep phenotypes in humans
Cheng H
Communications biology
2022; 5: 405
100337
Clinical Analysis of Pediatric Glaucoma in Central China
Yang X; Dong Y
Frontiers in medicine
2022; 9: 874369
100683
Gastrodin protects retinal ganglion cells from ischemic injury by activating phosphatidylinositol 3-kinase/protein kinase B/nuclear factor erythroid 2-related factor 2 (PI3K/AKT/Nrf2) signaling pathway
Liu Y
Bioengineered
2022; 13: 12625-12636
100469
Genome-wide association and Mendelian randomization study of blood copper levels and 213 deep phenotypes in humans
Ge X
Communications biology
2022; 5: 405
100683
Gastrodin protects retinal ganglion cells from ischemic injury by activating phosphatidylinositol 3-kinase/protein kinase B/nuclear factor erythroid 2-related factor 2 (PI3K/AKT/Nrf2) signaling pathway
Hao K
Bioengineered
2022; 13: 12625-12636
100337
Clinical Analysis of Pediatric Glaucoma in Central China
Feng X
Frontiers in medicine
2022; 9: 874369
100469
Genome-wide association and Mendelian randomization study of blood copper levels and 213 deep phenotypes in humans
Bao Y
Communications biology
2022; 5: 405
100337
Clinical Analysis of Pediatric Glaucoma in Central China
Cheng W
Frontiers in medicine
2022; 9: 874369
100469
Genome-wide association and Mendelian randomization study of blood copper levels and 213 deep phenotypes in humans
Huang L
Communications biology
2022; 5: 405
100683
Gastrodin protects retinal ganglion cells from ischemic injury by activating phosphatidylinositol 3-kinase/protein kinase B/nuclear factor erythroid 2-related factor 2 (PI3K/AKT/Nrf2) signaling pathway
Fu M
Bioengineered
2022; 13: 12625-12636
100469
Genome-wide association and Mendelian randomization study of blood copper levels and 213 deep phenotypes in humans
Wang F; Liu C; Chen X; Mo Z; Yang X
Communications biology
2022; 5: 405
Issue
23-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement